Blog

Sherene Loi: Long-Term affects of Adjuvant Breast Cancer Treatment on Lymphocyte Counts

industry.gov.au

Nov 1, 2024, 11:28

Sherene Loi: Long-Term affects of Adjuvant Breast Cancer Treatment on Lymphocyte Counts

Sherene Loi, Medical Oncologist, Lab Head of Breast Oncology Clinical Trials at Peter MacCallum Cancer Centre, shared on X:

“Sharing our latest article: Here we show that dose dense AC-T, radiotherapy and age affects long-term lymphocyte counts post adjuvant breast cancer treatment ?implications for IO therapy.”

Sustained lymphocyte decreases after treatment for early breast cancer

Authors: Julia Dixon-Douglas, Balaji Virassamy, Kylie Clarke, Michael Hun, Stephen J. Luen, Peter Savas, Courtney T. van Geelen, Steven David, Prudence A. Francis, Roberto Salgado, Stefan Michiels, Sherene Loi

Sherene Loi

More posts featuring Immunotherapy on oncodaily.com

Balaji Virassamy cancer Courtney T. van Geelen Julia Dixon-Douglas Kylie Clarke Michael Hun OncoDaily Oncology Peter Savas Prudence A. Francis radiotherapy Roberto Salgado Sherene Loi Stefan Michiels Stephen J. Luen Steven David

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage